SCHEMBL6979690

SCHEMBL6979690

O=c1ccn2c3ccccc3c3cc(Cl)cc1c32

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
PARP1 P09874 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
CHEK1 O14757 1/20 0.33
PTPN1 P18031 1/20 0.33
PLK1 P53350 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 2/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
EGFR P00533 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980855 0.85 DNMT1 (0.36) MEN1KMT2AHPGDL3MBTL1CHEK1
SCHEMBL6980643 0.82 KDM4E (0.42) MEN1KMT2AMAPTKDM4EHPGD
SCHEMBL6979022 0.81 PGR (0.39) MEN1KMT2AMAPTKDM4EHPGD
SCHEMBL6976283 0.81 CA1 (0.43) KDM4EHPGDALDH1A1PARP1
SCHEMBL6975999 0.81 KDM4E (0.47) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL6976281 0.80 NPC1 (0.41) MEN1KMT2AMAPTKDM4EHPGD
SCHEMBL6974173 0.79 MGLL (0.39) MEN1KMT2AMAPTKDM4EPARP1
SCHEMBL6976466 0.77 NR4A2 (0.43) MEN1KMT2AMAPTKDM4EHPGD
SCHEMBL6976313 0.76 EGFR (0.40) MEN1KMT2AKDM4EHPGDALDH1A1
SCHEMBL7662145 0.76 P2RX4 (0.43) MEN1KMT2AMAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed